Vistagen Therapeutics (VTGN) Change in Accrued Expenses (2010 - 2026)
Vistagen Therapeutics (VTGN) reported Change in Accrued Expenses of -$2.52 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with $3.2 million a year earlier.
Vistagen Therapeutics (VTGN) Change in Accrued Expenses (2010 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Change in Accrued Expenses of $828,000, down 85.4% from FY2025.
- Change in Accrued Expenses has a five-year compound annual growth rate of 74.6% (FY2021 to FY2026).
- By fiscal year, Change in Accrued Expenses came in at $5.68 million in FY2025 (+988.3%), $522,000 in FY2024, -$934,000 in FY2023 and $1.69 million in FY2022.
- The fiscal Q2 2027 figure ranks as the lowest quarterly Change in Accrued Expenses in data going back to fiscal Q1 2012.
- Year over year, Change in Accrued Expenses gained in three of the last four quarters, with growth averaging 192.6%.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -$53,000 (Q1 2027), -$243,000 (Q4 2026) and $294,000 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 397,968.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | - |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 2.41 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 983.00 Mn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | - |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | -2.52 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.52 Mn |
| Jun 30, 2026 | -53,000.00 |
| Mar 31, 2026 | -243,000.00 |
| Dec 31, 2025 | 294,000.00 |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | -2.42 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -455,000.00 |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | -450,000.00 |
| Jun 30, 2023 | -1.21 Mn |
| Mar 31, 2023 | 575,500.00 |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | -2.05 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | -488,400.00 |
| Dec 31, 2021 | -1.51 Mn |
Vistagen Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();